: Established a strategic collaboration with Cepheid (a Danaher subsidiary) to develop automated infectious disease sequencing solutions. Leadership Update
: Completed a programme resulting in an approximately 5% reduction in workforce to reallocate capital to growth areas. : Established a strategic collaboration with Cepheid (a
Co-founder and CEO announced he will step down from his role and the board by the end of 2026. : Established a strategic collaboration with Cepheid (a
: Continued advancement in national programs like NIHR Bioresource. Strategic and Operational Developments : Established a strategic collaboration with Cepheid (a